SEND対応サービス提供しています.SNBL is SEND ready

2016年12月17日以降に開始する単回投与毒性試験,反復投与毒性試験,がん原性試験においてFDAは,Standard for Exchange of Nonclinical Data (SEND)フォーマットを用いての電子申請を要求しています.SNBLでは,独自のデータ収集システム及びPinnacle 21 Enterpriseを用いて申請に必要なデータを提供致します.




The FDA requires data from single and repeated-dose general toxicity and carcinogenicity pre-clinical studies that begin after December 17, 2016 to be submitted electronically in Standard for Exchange of Nonclinical Data (SEND) format. SNBL uses our custom data collection system and Pinnacle 21 Enterprise to produce datasets for our pre-clinical studies. We completed validation of our SEND process earlier this year and we are ready to deliver SEND data packages.

Please email us to discuss how we can partner with you on SEND solutions for your preclinical needs.